News >

Case Studies Showcase Recent Advances in Nonsquamous, Squamous NSCLC

Gina Columbus @ginacolumbusonc
Published: Thursday, Aug 22, 2019

Roy Herbst, MD, PhD

Roy S. Herbst, MD, PhD

Practice-changing phase III trials including KEYNOTE-189, KEYNOTE-407, REVEL, and IMpower131, among several others, are laying the groundwork for how to treat patients with non–small cell lung cancer (NSCLC), specifically on an individualized basis.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Medical Crossfire®: Experts Weigh-In on Emerging Immune Checkpoint Inhibitors and Combination Strategies for Advanced NSCLCNov 30, 20191.5
Publication Bottom Border
Border Publication